NCT06600282

Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions

A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Parecoxib After Intravenous Bolus of Parecoxib in Healthy Volunteers Under Fasting Conditions

• Status: Not Yet Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 14 (estimated)
• Sponsor: Yung Shin Pharm. Ind. Co., Ltd. · Industry
• Sex: All
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of parecoxib after intravenous bolus of parecoxib in healthy volunteers under fasting conditions

Conditions

• Post-operative Pain
• Bioequivalence Study in Healthy Subjects

Interventions

Type	Name	Description
DRUG	Parecoxib	Pharmacokinetic study under fasting conditions

Timeline

• Start date: 2024-10-01
• Primary completion: 2024-11-30
• Completion: 2024-12-30
• First posted: 2024-09-19
• Last updated: 2024-09-20

Locations

1 site across 1 country: Taiwan